Literature DB >> 9207926

Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts.

F Paoletti1, A Mocali, D Tombaccini.   

Abstract

Cultured fibroblasts from patients affected by Alzheimer's disease (AD) exhibited peculiar alterations of the enzyme transketolase (TK). Abnormalities (dubbed alkaline bands, ab) consisted of enzyme forms having unusually high pl and were proposed as a marker of the disease in living patients. The mechanisms of TK-ab expression were investigated with the use of cysteine proteinase inhibitors and purified preparations of either rat liver or human cysteine proteinases. The cysteine proteinase inhibitors N-acetyl-leu-leu-norleucinal (ALLN), L-trans-Epoxy-succinyl-leucylamido(4-guanidino)butane (E-64), and egg white cystatin added to AD cells just prior to extraction abolished TK abnormalities. Moreover, 1 day incubation of AD cultures with either ALLN (10 micrograms/ml), NH4Cl (10 mM), or KCl (30 mM) prevented TK-ab generation, due, presumably, to an impairment of lysosomal functions. Isolated rat liver cysteine proteinases were able to degrade TK in normal extracts and reproduce the characteristic TK-ab of AD fibroblasts. Moreover, pure human cathepsin H was also shown to partially induce an Alzheimer-like TK pattern and cleave normal TK to a 35 kDa fragment as spontaneously occurring in AD fibroblasts. The explanation of mechanisms of TK-ab formation provided evidence for an underlying imbalance of proteolysis in AD fibroblasts due to a relative increase/derangement of the cysteine proteinases cathepsins which might be also involved in the reported abnormal processing of multiple cellular components.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207926     DOI: 10.1002/(SICI)1097-4652(199707)172:1<63::AID-JCP7>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.

Authors:  Carmela Ricciardelli; Noor A Lokman; Sowmya Cheruvu; Izza A Tan; Miranda P Ween; Carmen E Pyragius; Andrew Ruszkiewicz; Peter Hoffmann; Martin K Oehler
Journal:  Clin Exp Metastasis       Date:  2015-04-21       Impact factor: 5.150

Review 2.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

3.  Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice.

Authors:  Zheng-Ping Xu; Eric F Wawrousek; Joram Piatigorsky
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 4.  A review on research progress of transketolase.

Authors:  Jing Zhao; Chun-Jiu Zhong
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

5.  Function of the pentose phosphate pathway and its key enzyme, transketolase, in the regulation of the meiotic cell cycle in oocytes.

Authors:  Yunna Kim; Eun-Young Kim; You-Mi Seo; Tae Ki Yoon; Woo-Sik Lee; Kyung-Ah Lee
Journal:  Clin Exp Reprod Med       Date:  2012-06-30

6.  Altered proteolysis in fibroblasts of Alzheimer patients with predictive implications for subjects at risk of disease.

Authors:  Alessandra Mocali; Nunzia Della Malva; Claudia Abete; Vito Antonio Mitidieri Costanza; Antonio Bavazzano; Vieri Boddi; Luis Sanchez; Sandra Dessì; Alessandra Pani; Francesco Paoletti
Journal:  Int J Alzheimers Dis       Date:  2014-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.